GeNeuro Announces Results of the GNC-501 Study in Post-Covid-19 Syndrome
"The GNC-501 clinical trial is a Phase 2 study in patients suffering from post-COVID-19 neuropsychiatric syndromes, testing temelimab against placebo. The study enrolled over 200 patients in Switzerland, Spain and Italy...
As $20 per month is kind of significant for me, and it doesn't seem like this is being used a lot, and I don't need ChatGPT Premium for anything else, I'll be canceling my subscription. ME/GPT will continue to be available until July 1st.
If anyone else has a premium subscription and wants to...
I just can't think of anything else. Maybe because it's gotten slower, but it didn't get much slower on the 18th and beyond as far as I know.
I wouldn't think it'd be a constant 10k though, since it probably grew in views over time and wouldn't have 10k/day immediately.
I thought maybe it would line up with searches on Google for ME/CFS, but it seems to be pretty consistent over the past 90 days.
My guess would still be the Twitter campaign made it popular temporarily.
Hypocortisolemic ASIA: A vaccine-and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis (Provisionally accepted)
Manuel Ruiz-Pablos 1, Aintzane Zabaleta 2, Bruno Paiva 2
1 Complutense University of Madrid, Madrid, Madrid, Spain
2 Center of Applied...
From ME/GPT AI:
Multiple Sclerosis (MS)
Systemic Lupus Erythematosus (SLE or Lupus)
Celiac Disease
Hashimoto’s Thyroiditis
Endometriosis
Migraine
Honorable mentions because they satisfy all but female preponderance criteria (before treatments and tests were developed)...
I put "unaffiliated" under institution and gave a brief description of what I'd hope to use the data for when I applied a couple months ago, and my account was approved. I can't remember how long it took to be approved.
Edit: I remembered I can check my emails for dates. It took four days to be...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.